NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call
April 15 2021 - 1:00PM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its 2021 first quarter financial results before the opening
of the market on April 22, 2021. The Company will host a conference
call at 8:00 a.m., Eastern Time on April 22, 2021 to discuss its
financial results as well as business developments affecting the
Company.
The conference call may be accessed in the United States by
dialing 844-787-0799 and using the confirmation code 9554608.
Internationally, the conference call may be accessed by dialing
661-378-9630 and using the same confirmation code. The earnings
press release and accompanying condensed financial statements will
be accessible from the Company's website at www.NeuroMetrix.com
under the "Investor Relations" tab.
A replay of the conference call will be available starting two
hours after the call by dialing 855-859-2056, domestically and
404-537-3406, internationally. The confirmation code to access the
replay is 9554608. The replay will be available for one week after
the conference call.
About NeuroMetrix
NeuroMetrix is an innovation-driven company focused on the
development and global commercialization of non-invasive medical
devices for the diagnosis and treatment of disorders involving the
nervous system. The Company has three commercial products.
DPNCheck® is a diagnostic device that provides rapid, point-of-care
detection of peripheral neuropathies. ADVANCE® is a diagnostic
device that provides automated, in-office nerve conduction studies
for the evaluation of focal neuropathies. Quell® is a wearable
neurostimulation device indicated for symptomatic relief of chronic
pain that is available over-the-counter. For more information,
visit www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024